The FDA had logged more than 455 adverse event reports tied to compounded semaglutide and more than 320 tied to compounded tirzepatide as of early 2025
As research continues, patients and healthcare providers will be watching closely for updates on this exciting possibility
GLP-1 research has diversified to include non-alcoholic fatty liver disease, weight loss to help with polycystic ovary syndrome, cardiovascular health, Alzheimers, arthritis and sleep apnea
This makes the Myers Cocktail an effective treatment for conditions characterized by chronic inflammation
By improving metabolic function, GLP-1RAs may not only enhance disease control but also optimize responses to concomitant therapies during the critical early phases of PsA
They contain the same active ingredient, in the same doses, and are both injected into your skin once a week